High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
Martin Lang(Eurac Research), W. Marston Linehan(National Cancer Institute)
Cited by 18
Related Papers
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
|Nature Communications|2021|167
Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
|PLoS ONE|2013|110
Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt–Hogg–Dubé tumors
|Modern Pathology|2015|30